4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > Other_reagents > Adipogen/Z-Leu-Leu-Leu-CHO [MG-132]/AG-CP3-0011-M025/25 mg
商品详细Adipogen/Z-Leu-Leu-Leu-CHO [MG-132]/AG-CP3-0011-M025/25 mg
Adipogen/Z-Leu-Leu-Leu-CHO [MG-132]/AG-CP3-0011-M025/25 mg
Adipogen/Z-Leu-Leu-Leu-CHO [MG-132]/AG-CP3-0011-M025/25 mg
商品编号: AG-CP3-0011-M025
品牌: Adipogen Inc
市场价: ¥3300.00
美元价: 1980.00
产地: 美国(厂家直采)
公司:
产品分类: 其他试剂
公司分类: Other_reagents
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
MoreInformation
ProductDetails
SynonymsZ-LLL-CHO;Carbobenzoxy-L-leucyl-L-leucyl-L-leucinal;MG132
ProductTypeChemical
Properties
FormulaC26H41N3O5
MW475.6
SequenceZ-Leu-Leu-Leu-aldeyhde
CAS133407-82-6
RTECSOH2824610
PurityChemicals≥97%(HPLC)
AppearanceWhitesolid.
SolubilitySolubleinDMSOorethanol.
InChiKeyTZYWCYJVHRLUCT-VABKMULXSA-N
ShippingandHandling
ShippingAMBIENT
ShortTermStorage+4°C
LongTermStorage-20°C
HandlingAdviceKeepcoolanddry.
Use/StABIlityStableforatleast2yearsafterreceiptwhenstoredat-20°C.
Documents
MSDSDownloadPDF
ProductSpecificationSheet
DatasheetDownloadPDF
  • Potent,cellpermeableandselective,reversIBLeproteasomeinhibitor[2,7].
  • Blocksdegradationofshort-livedproteinsandinducesaheatshockresponse[2,6,7].
  • NF-κBactivationinhibitorthroughIκBdegradation[3,8].
  • Cellpermeable,reversiblepeptidealdehydeinhibitor.Calpainandcathepsininhibitor[4,11].
  • Hasanticancerpropertiesbyinducingcellcyclearrestandactivatingapoptosisinvariouscancercelllines[8,9,12,13,15].
  • Hasadjuvant/chemosensitizerpotential[8].
  • NeuriteoutgrowthstimulatorinPC12cells[1].
  • Preventsβ-secretasecleavage[5,10].
  • Autophagyactivator[12,14].
ProductReferences
  1. IsolationandcharacterizationofpossibletargetproteinsresponsibleforneuriteoutgrowthinducedbyatripeptidealdehydeinPC12Hcells:Y.Saito,etal.;BBRC184,419(1992)
  2. InhibitorsoftheproteasomeblockthedegradationofmostcellproteinsandthegenerationofpeptidespresentedonMHCclassImolecules:K.L.Rock,etal.;Cell78,761(1994)
  3. Theubiquitin-proteasomepathwayisrequiredforprocessingtheNF-kappaB1precursorproteinandtheactivationofNF-kappaB:V.J.Palombella,etal.;Cell78,773(1994)
  4. Differentialinhibitionofcalpainandproteasomeactivitiesbypeptidylaldehydesofdi-leucineandtri-leucine:S.Tsubuki,etal.;J.Biochem.119,572(1996)
  5. Thecarboxylterminiofbeta-amyloidpeptides1-40and1-42aregeneratedbydistinctgamma-secretaseactivities:H.Klafki,etal.;J.Biol.Chem.271,28655(1996)
  6. Proteasomeinhibitionleadstoaheat-shockresponse,inductionofendoplasmicreticulumchaperones,andThermotolerance:K.T.Bush,etal.;J.Biol.Chem.272,9086(1997)
  7. Proteasomeinhibitors:valuablenewtoolsforcellBIOLOGists:D.H.Lee&A.L.Goldberg;TrendsCellBiol.8,397(1998)
  8. InhibitionofNF-kappaBsensitizeshumanpancreaticcarcinomacellstoapoptosisinducedbyetoposide(VP16)ordoxorubicin:A.Arlt,etal.;Oncogene20,859(2001)
  9. PotentialoftheproteasomalinhibitorMG-132asananticanceragent,aloneandincombination:D.Banerjee&A.Liefshitz;AnticancerRes.21,3941(2001)
  10. Theproteaseinhibitor,MG132,blocksmaturationoftheamyloidprecursorproteinSwedishmutantpreventingcleavagebybeta-Secretase:M.L.Steinhilb,etal.;J.Biol.Chem.276,4476(2001)
  11. TheproteasomeinhibitorMG132protectsagainstacutepancreatitis:T.Letoha,etal.;FreeRADIc.Biol.Med.39,1142(2005)
  12. Inductionofautophagybyproteasomeinhibitorisassociatedwithproliferativearrestincoloncancercells:W.K.Wu,etal.;BBRC374,258(2008)
  13. Synthesis,radiosynthesis,andbiologicalevaluationofnewproteasomeinhibitorsinatumortargetingapproach:M.Vivier,etal.;J.Med.Chem.51,1043(2008)
  14. Mechanismsofcross-talkbetweentheubiquitin-proteasomeandautophagy-lysosomesystems:V.I.Korolchuk,etal.;FEBSLett.584,1393(2010)
  15. MG132,aproteasomeinhibitor,inducesapoptosisintumorcells:N.Guo&Z.Peng;AsiaPac.J.Clin.Oncol.9,6(2013)
  16. AQP2AbundanceisRegulatedbytheE3-LigaseCHIPViaHSP70:M.Centrone,etal.;CellPhysiol.Biochem.44,515(2017)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。